首页> 外文期刊>BMC Pregnancy and Childbirth >Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis
【24h】

Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis

机译:系统性红斑狼疮与原发性和继发性抗磷脂综合征的孕妇的动脉/静脉血栓形成,胎儿丢失和死产:系统评价和荟萃分析

获取原文
       

摘要

We aimed to systematically compare arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus (SLE), primary anti-phospholipid syndrome (PAPS) and secondary anti-phospholipid syndrome (SAPS). Online databases were carefully searched for relevant publications comparing SLE with PAPS and/or SAPS in pregnancy. Studies were included if: they compared SLE with APS [SLE versus PAPS or SLE versus SAPS or SLE versus PAPS and SAPS respectively] in pregnant women; and they reported specific adverse outcomes as their clinical endpoints including arterial/venous thrombosis, fetal loss and stillbirth. Risk ratios (RR) with 95% confidence intervals (CIs) were used as statistical parameters and the analysis was carried out by the RevMan 5.3 software. A total number of 941 pregnant women were included: 556 were candidates of SLE; 200 were candidates of PAPS; and 185 were candidates of SAPS. APS was associated with a significantly higher risk of fetal loss (RR: 4.49, 95% CI: 2.09–9.64; P?=?0.0001). In addition, stillbirth and arterial/venous thrombosis were also significantly increased with APS (RR: 6.65, 95% CI: 2.14–20.60; P?=?0.001) and (RR: 3.95, 95% CI: 1.28–12.16; P?=?0.02) respectively. When patients with PAPS were compared with patients who suffered from SLE alone, fetal loss and arterial/venous thrombosis were still significantly higher with the former. When SAPS were compared with SLE (without anti-phospholipid antibodies), arterial/venous thrombosis, stillbirth and fetal loss were still significantly higher with SAPS. However, no significant difference was observed in arterial/venous thrombosis and fetal loss between PAPS and SAPS. PAPS and SAPS were associated with significantly higher arterial/venous thrombosis, fetal loss and stillbirth in comparison to SLE. However, no significant difference was observed when PAPS was compared to SAPS.
机译:我们旨在系统比较系统性红斑狼疮(SLE),原发性抗磷脂综合征(PAPS)和继发性抗磷脂综合征(SAPS)的孕妇的动脉/静脉血栓形成,胎儿丢失和死产。认真搜索在线数据库以查找相关出版物,以比较妊娠期SLE与PA​​PS和/或SAPS。如果包括以下内容,则进行研究:将孕妇的SLE与APS进行比较[分别为SLE与PA​​PS或SLE与SAPS或SLE与PA​​PS和SAPS]。他们报告了特定的不良结局为临床终点,包括动脉/静脉血栓形成,胎儿丢失和死产。具有95%置信区间(CI)的风险比(RR)用作统计参数,并通过RevMan 5.3软件进行分析。总共包括941名孕妇:556名SLE候选人; 200名PAPS候选人; 185名是SAPS的候选人。 APS与明显的胎儿丢失风险相关(RR:4.49,95%CI:2.09–9.64; P = 0.0001)。此外,APS的死产和动脉/静脉血栓形成也显着增加(RR:6.65,95%CI:2.14-20.60; P <= 0.001)和(RR:3.95,95%CI:1.28-12.16; P?)。 =?0.02)。当将PAPS患者与仅患有SLE的患者进行比较时,前者的胎儿丢失和动脉/静脉血栓形成仍显着更高。当将SAPS与SLE(无抗磷脂抗体)进行比较时,SAPS的动脉/静脉血栓形成,死产和胎儿流失率仍然明显更高。但是,PAPS和SAPS之间在动脉/静脉血栓形成和胎儿丢失方面未观察到显着差异。与SLE相比,PAPS和SAPS与明显更高的动脉/静脉血栓形成,胎儿丢失和死产相关。但是,将PAPS与SAPS进行比较时,没有观察到显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号